Revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Becton Dickinson & Co (BDX)
Price$181.97Cached quote
Net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B | $16.07B | $17.29B | $15.98B | $12.09B | $12.48B | $10.28B | $8.45B | $8.05B | $7.71B | $7.58B | $7.12B | $6.99B | $6.90B | $6.28B |
| Gross profit | $9.93B | $9.13B | $8.17B | $8.48B | $8.63B | $7.58B | $8.29B | $7.27B | $5.94B | $5.99B | $4.70B | $4.30B | $4.17B | $3.95B | $3.96B | $3.70B | $3.68B | $3.54B | $3.25B |
| Gross margin | 45.44% | 45.22% | 42.17% | 44.92% | 45.12% | 47.14% | 47.94% | 45.48% | 49.14% | 47.99% | 45.66% | 50.92% | 51.79% | 51.28% | 52.20% | 51.88% | 52.60% | 51.33% | 51.73% |
| Research & development | $1.26B | $1.19B | $1.24B | $1.26B | $1.28B | $1.04B | $1.06B | $1.00B | $770.0M | $828.0M | $632.0M | $550.0M | $494.0M | $472.0M | $470.0M | $422.8M | $404.6M | — | — |
| Operating expenses | $19.26B | $17.78B | $17.26B | $16.59B | $16.88B | $15.16B | $15.53B | $14.47B | $10.57B | $11.05B | $9.21B | $6.84B | $6.80B | $6.15B | $5.92B | $5.54B | $5.40B | $5.41B | $5.10B |
| Operating income | $2.58B | $2.40B | $2.11B | $2.28B | $2.25B | $912.0M | $1.76B | $1.51B | $1.52B | $1.43B | $1.07B | $1.61B | $1.25B | $1.56B | $1.67B | $1.58B | $1.59B | $1.49B | $1.18B |
| Operating margin | 11.81% | 11.88% | 10.90% | 12.09% | 11.76% | 5.67% | 10.18% | 9.44% | 12.59% | 11.46% | 10.45% | 19.01% | 15.57% | 20.21% | 21.97% | 22.21% | 22.75% | 21.57% | 18.86% |
| EBITDA | $5.04B | $4.68B | $4.40B | $4.51B | $4.48B | $3.03B | $4.01B | $3.49B | $2.61B | $2.54B | $1.97B | $2.17B | $1.80B | $2.07B | $2.16B | $2.07B | $2.05B | $1.96B | $1.63B |
| EBITDA margin | 23.08% | 23.21% | 22.71% | 23.91% | 23.42% | 18.83% | 23.21% | 21.82% | 21.58% | 20.38% | 19.11% | 25.67% | 22.35% | 26.84% | 28.48% | 29.11% | 29.40% | 28.42% | 25.88% |
| Net income | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B | $874.0M | $1.23B | $311.0M | $1.10B | $976.0M | $695.0M | $1.19B | $1.29B | $1.17B | $1.27B | $1.32B | $1.23B | $1.13B | $890.0M |
| Net profit margin | 7.68% | 8.45% | 7.66% | 9.43% | 10.94% | 5.44% | 7.13% | 1.95% | 9.10% | 7.82% | 6.76% | 14.03% | 16.05% | 15.18% | 16.76% | 18.49% | 17.63% | 16.34% | 14.17% |
| Basic EPSper basic share | $5.83 | $5.88 | $4.97 | $5.93 | $6.92 | $2.75 | $4.01 | $0.62 | $4.70 | $4.59 | $3.43 | $6.13 | $6.63 | $5.69 | $5.75 | $5.62 | $5.12 | $4.61 | $3.63 |
| Diluted EPSper diluted share | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 | $2.71 | $3.94 | $0.60 | $4.60 | $4.49 | $3.35 | $5.99 | $6.49 | $5.59 | $5.62 | $5.49 | $4.99 | $4.46 | $3.49 |
Owners
Reported shareholders
10.14%of listed shares
First Eagle Investment Management, LLC27.63M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
First Eagle Investment Management, LLC | 10.14%27.63M shares |
BlackRock, Inc. | 9.03%24.59M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 6.60%17.99M shares |
STATE STREET CORP | 5.51%15M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 5.50%14.97M shares |
Invesco Ltd. | 3.27%8.9M shares |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3.18%8.65M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.99%8.14M shares |
FRANKLIN RESOURCES INC | 2.57%7.01M shares |
WELLINGTON MANAGEMENT GROUP LLP | 2.33%6.36M shares |
GREENHAVEN ASSOCIATES INC | 2.09%5.68M shares |
NORGES BANK | 1.53%4.17M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 1.43%3.91M shares |
T. Rowe Price Investment Management, Inc. | 1.37%3.72M shares |
AMERICAN CENTURY COMPANIES INC | 1.35%3.68M shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.25%3.4M shares |
MORGAN STANLEY | 1.22%3.32M shares |
Clearbridge Investments, LLC | 1.19%3.23M shares |
BANK OF AMERICA CORP /DE/ | 1.15%3.14M shares |
JPMORGAN CHASE & CO | 1.04%2.84M shares |
Percentages use 272.39M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026Form 4 · 10b5-1 | Feld MichaelEVP, Chief Revenue Officer | SellCommon Stock | 75 | $152.80 | $11.5K | 21.0K |
| Jun 24, 2026Form 4 · 10b5-1 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | SellCommon Stock | 1.1K | $145.66 | $160.2K | 13.2K |
| Jun 10, 2026Form 4 · 10b5-1 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | SellCommon Stock | 1.1K | $151.48 | $166.6K | 14.3K |
| Jun 1, 2026Form 4 · 10b5-1 | Polen Thomas E JrChairman, CEO and President | SellCommon Stock | 2.8K | $146.35 | $404.5K | 110.2K |
| May 26, 2026Form 4 · 10b5-1 | Feld MichaelEVP, Chief Revenue Officer | SellCommon Stock | 75 | $147.35 | $11.1K | 21.1K |